US$ 27.11
lily glp 1 Eli Lilly stock soars on encouraging results for daily weight-loss pill Lilly's oral GLP-1 Foundayo (orforglipron)
Description
That proof-of-concept opened the door for larger pharmaceutical companies to engineer more potent versions

doi: 10.1093/ibd/izy278
Less frequent dosing may outweigh the discomfort of a little jab

This doesnt mean everyone with obesity has a GLP-1 issue and, ultimately, people must change their behaviors to improve their outcomes
This does not change the 72-hour minimum rule, but it means that the side effect profile at a given dose may shift as your weight changes
Overview of the diagnosis and management of diabetic ketoacidosis
